Limedix GmbH
PrivateLast Round
Grant
Feb 2, 2026
Total Funding Raised
$1.03M
Company Overview
Limedix GmbH operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Grant round in February 2026.
Limedix GmbH is a health technology company that develops digital speech therapy applications for patients with speech disorders, such as aphasia and articulation disorders.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limedix GmbH Comparables
Compare Limedix GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lingo Lab UG | 89% | |
| SpeechCare GmbH | 87% | |
| Pappy GmbH | 76% |
For institutional investors. Book with your work email.
Limedix GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2026 | ||||
| Grant | Jul 8, 2022 | ||||
| Grant | Nov 18, 2020 | ||||
| Grant | Jul 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Limedix GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| FilmFernsehFonds Bayern | Grant |
| Friedrich-Alexander-Universität Erlangen-Nürnberg | Grant |
| EIT Health | Grant |
| Federal Ministry for Economic Affairs and Energy | Grant |
| Ludwig-Maximilians-Universität München | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 217% MoM, reaching 4.4K.
- Jun 6, 2025
Grew 30% QoQ, from 10 to 13 employees.
For institutional investors. Book with your work email.
Limedix GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Limedix GmbH's valuation, stock price, and market status.
Is Limedix GmbH a public or private company?
Limedix GmbH is a private company.
What is the current stock price of Limedix GmbH?
Limedix GmbH is a private company, so its shares have no public market price. Caplight tracks Limedix GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Limedix GmbH worth (valuation)?
Valuation information for Limedix GmbH is not publicly available.
Can I buy Limedix GmbH stock?
Limedix GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Limedix GmbH's last funding round?
Limedix GmbH's most recent funding round was Grant on February 2, 2026.
Who are the main investors in Limedix GmbH?
Key investors in Limedix GmbH include Bundesministerium für Bildung und Forschung, FilmFernsehFonds Bayern, EIT Health, Federal Ministry for Economic Affairs and Energy.
Will Limedix GmbH IPO soon?
No public IPO plans have been announced for Limedix GmbH.
How can I track Limedix GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Limedix GmbH's shares on secondary markets.